Expands range of applications for successful QIAcuity digital PCR platforms, now entering the clinical space across North America and the EU // Provides absolute quantitation, essential for precise ...
LOS ANGELES--(BUSINESS WIRE)--BiologyWorks™, Inc., a digital healthcare platform company, today announced that a substantive clinical trial of its handheld, reusable molecular test for COVID-19 ...
Medical Device Network on MSN
Countable Labs raises $26M for PCR technology advancement
Countable Labs claims that its Countable PCR technology is “at least 10 times” more sensitive than conventional PCR.
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Liquid biopsies used to identify and track genetic mutationsin cancer patinets, enabling researchers to detect cancer early, measure therapeutic response, quantify residual tumor burden, and monitor ...
Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...
Ongoing verification study supports compatibility of DeepChek® with the AVITI™ platform. Expands opportunities in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results